Our Vision is to improve healthcare as a global provider of innovative and reliable diagnostic tests.
Our Mission is to identify and develop novel patentable diagnostic markers and technologies which can be commercialised to meet clinical needs.
We specialise in proprietary markers for the early diagnosis and management of critical illnesses including:
Active-B12 for the assessment of Vitamin B12 deficiency. Our exclusive assay measures Holotranscobalamin, the bio-active form of Vitamin B12 in the circulation and provides a more accurate estimate of Vitamin B12 status than current tests.
Anti-CCP for measurement of antibodies to cyclic citrullinated peptides for use in the diagnosis and management of Rheumatoid Arthritis.
Homocysteine The current movement of testing away from immunoassay techniques to the more convenient clinical chemistry technology is exemplified by our homogeneous liquid stable kit for measuring this important marker.
Heparin Binding Protein for use in the risk assessment of patients with suspected sepsis. HBP shows good predictive ability at being able to accurately idenify those patients that will progress from sepsis to a more severe form of the disease.
For more information on any of these markers or to purchase a kit, please contact us.